Chitooligosaccharide-modified PLGA-loaded PPD nanoparticles ameliorated sepsis-associated acute kidney injury <i>via</i> the NF-κB signaling pathway
COS-PLGA-PPD NPs ameliorate LPS-induced SA-AKI in rats by inhibiting the NF-κB signaling pathway, providing a basis for the treatment of SA-AKI.
Authors
- Yawen Yu
- Xinxin Bai
- Tao Pan (ORCID: https://orcid.org/0000-0002-5055-5675)
- Zhixia Wang (ORCID: https://orcid.org/0000-0002-5242-3668)
- Ke Liu (ORCID: https://orcid.org/0009-0002-0594-4484)
- Teng Liu (ORCID: https://orcid.org/0000-0001-8300-8654)
- Yaping He (ORCID: https://orcid.org/0000-0002-5378-3809)
- Baifang Gong
- Huaying Fan (ORCID: https://orcid.org/0000-0001-6245-7450)
Institutions
- Yantai University (CN)
- Luye Pharma (China) (CN)
Publication Details
- Journal
- Drug Development and Industrial Pharmacy
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1080/03639045.2024.2434958
- Citations
- 2
- Primary Topic
- Acute Kidney Injury Research
- Type
- article
- Field-Weighted Citation Impact
- 0.68